Decoding Genomics

For a Healthier Future.

Who We Are

We turn complex genomics into simple solutions

We turn complex genomics into simple solutions. We’re a genomics research and diagnostics company, a subsidiary of Reliance Industries Limited. We began our journey as a bioinformatics start-up within the innovation ecosystem of the Indian Institute of Science (IISc) and were an early example of academic entrepreneurship in India. For the past 25 years, we’ve been tackling some of the toughest challenges in healthcare genomics. We transform complex genomic data into actionable insights, providing solutions in clinical diagnostics, translational medicine, bioinformatics, engineering, and science. By collaborating with global partners, we’re helping shape the future of personalized medicine.

Years of Experience

0 +

Citations & 80+ Publications

0 +

Genetic Tests Reported

0 K+

Strong network of Clinicians and Hospitals

0 K+

Countries

0 +

Tests & Services

Reproductive Health & Rare Disease

Empowering better outcomes in reproductive health and rare diseases through actionable genomic insights.

Oncology

We offer a comprehensive suite of advanced genetic and molecular tests for oncology, empowering clinicians

Research Services

We are more than a service provider—we are a partner in discovery, enabling the research that shapes the future of science

Genomic Wellness

The blueprint of life is stored in a biochemical molecule called DNA that is present in almost every cell of our body.

Genetic Counseling

Genetic counseling helps you understand genetic risks and make informed health decisions.

Carrier Screening

Exome Sequencing

Whole Genome Sequencing

Chromosomal Analysis

Mitochondrial Testing

NGS Targeted Panels

Comprehensive Cancer Panels

Speciality Non-NGS Panels

Liquid Biopsy

Early Detection Cancer Test

Informatics Capabilities

Strand Life Sciences is a multiomics research and diagnostics company that combines a long track record in bioinformatics with cutting-edge laboratory assays and a vast hospital partner network that enables omics-based biomarker discovery. Strand’s customers include global instrument, diagnostic, and pharmaceutical companies.

Data-Centric Solutions

Real World Data Standardization
Data Cleaning & Harmonization
Precision Analytics
Predictive Modeling
Machine Learning

Pharma & Biomarker Discovery

Public Datasets Curation
Multi-omics Analysis for Target Identification
Custom Bioinformatics Pipelines
Spatial & Single-cell Transcriptomics
Fragmentomics
Other NGS pipelines

NGS & PCR Diagnostics

Variant Mapping & Annotation
Variant and KB curation with Reporting
NGS Assay validation
Scale up & Deployment
Research Infrastructure Support

Curated Datasets

Software Development & QA
Algorithm Verification & Validation
Genomics Product Development
Cloud Migration with Integration

Why Genetic Testing Matters

Over 70 million people

in India suffer from rare and inherited conditions. Early genetic testing can lead to faster diagnosis and treatment.

Carrier screening can prevent inherited conditions in children

Testing before or during pregnancy helps couples make informed decisions.

Early diagnosis = Better outcomes

Delays in rare disease diagnosis average 7 years. Genetic testing can shorten this “Diagnostic Odyssey” and reduce long-term healthcare costs.

Genetic testing can guide targeted therapies-especially in:

Breast, Ovarian, Lung, and Colorectal cancers—improving survival and reducing trial-and-error treatments.

Genetic testing is now 30-40% more affordable than 5 years ago

20M new cases & 9.7M deaths in 2022

77% rise expected by 2050

Genetic testing helps us understand the blueprint of life to

drive innovations in diagnosis and health

Genetics in research powers discoveries across fields

1. Understanding disease mechanisms
2. Identifying biomarkers
3. Drug development

4. Population & evolutionary studies
5. Agrigenomics & environmental applications
6. Technology innovation

Why Choose Strand Life Sciences

Strand delivers accuracy you can act on, with the data, validation, and transparency needed for clinical, reproductive, and research decisions. Whether you’re a physician, patient, or partner, you know exactly what the test can (and cannot) tell you—with complete clarity.

Our Ethos: Quality Is Not An Option - It’s A Guarantee

Strand’s Quality Promise - SQF Framework

Confident in what’s found, Certain in what`s not.

What we do

Why it matters

100+ QC checks per test

Ensures precision at every analytical stage, reducing the chance of reporting error.

CAP and NABL-accredited

Regular audits with 100% compliance and top proficiency scores ensure gold-standard reliability.

Controls in every run

Guarantees internal validation for each batch—every result, every time.

Transparent documentation

All limitations are clearly identified; no hidden caveats or assumptions.

Reproducibility & consistency

Every test is backed by SOP-driven, audited processes for result stability and repeatability.

High sensitivity and specificity

All variant types are validated against positive and negative controls, reducing both false positives and false negatives.

A mislabeled sample or a false positive is a misdiagnosed life.

Unnecessary surgery. Aggressive therapy. Years lost. Trust lost.

Why Quality Matters

Specimen labelling errors occur in 1 in every 1,000 samples submitted to pathology labs
Even this 0.1% error rate in labelling can affect thousands
Studies have shown false positive rates of 1–3% in multi-gene panel testing, especially in low-quality labs or non-CLIA/CAP accredited labs
70% of medical decisions are influenced by lab results